ADXN logo

ADXN
Addex Therapeutics Ltd - ADR

2,574
Mkt Cap
$8.8M
Volume
1,009.00
52W High
$12.05
52W Low
$5.41
PE Ratio
-0.80
ADXN Fundamentals
Price
$7.00
Prev Close
$6.96
Open
$6.90
50D MA
$6.75
Beta
0.63
Avg. Volume
5,993.24
EPS (Annual)
-$8.67
P/B
0.91
Loading...
Loading...
Poll

Earnings Recap

Addex Therapeutics reported a net loss of CHF6.7M for 2025, compared to a net profit of CHF7.1M in 2024, with basic and diluted loss per share at CHF 0.06. Cash position was CHF1.6M.

Bullish

Addex Therapeutics advanced its GABAB PAM chronic cough candidate, regained rights to a Phase 2 mGlu2 PAM asset, and secured a Sinntaxis collaboration and Stalicla investment for neurological disorders.

Bearish

Addex Therapeutics reported a CHF6.7M net loss for 2025, a significant decline from 2024 profit, alongside a CHF1.7M decrease in cash and increased losses from associates.

Latest ADXN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.